Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00562016 · ClinicalTrials.gov registry record · Phase 3
Protect II, A Prospective, Multicenter Randomized Controlled Trial
A Phase 3 study, sponsored by Abiomed.
- Terminated
- Registry status
- Phase 3
- Development phase
- 452
- Enrollment target
NCT00562016 is a Phase 3 study that was terminated before completion, run by Abiomed. The registered enrollment target is 452 participants.
The verdict
NCT00562016, a Phase 3 study, was terminated before completion, sponsored by Abiomed.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 452 participants
- Enrollment target
Study Summary
The IMPELLA® 2.5 System will be superior to Intra Aortic Balloon Pump in preventing the composite rate of major adverse events during and after the PCI procedure.
Interventions
- DEVICE IABP Intra-aortic balloon pump
- DEVICE IMPLELLA LP 2.5
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 452 participants |
| Start Date | 2007-10 |
| Est. Completion | 2011-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00562016
The ClinicalTrials.gov registry entry for NCT00562016 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 452 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abiomed, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which IABP Intra-aortic balloon pump is the first listed.
NCT00562016 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00562016 about?
NCT00562016 is a clinical study titled "Protect II, A Prospective, Multicenter Randomized Controlled Trial". The IMPELLA® 2.5 System will be superior to Intra Aortic Balloon Pump in preventing the composite rate of major adverse events during and after the PCI procedure.
What is the current status of trial NCT00562016?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 452 participants. The study started on 2007-10. Estimated completion is 2011-09.
What interventions are being tested in trial NCT00562016?
The interventions under investigation include: IABP Intra-aortic balloon pump (DEVICE), IMPLELLA LP 2.5 (DEVICE).
Who is sponsoring clinical trial NCT00562016?
This trial is sponsored by Abiomed, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.